Verve Therapeutics - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $99,467.75 +0.71%
Ethereum $3,299.25 -1.52%
BNB $623.04 +0.18%
Optimism $2.11 +2.86%
Arbitrum $0.77 +0.38%
Solana $254.01 -0.61%
Polygon $0.48 +7.00%
Cosmos $7.30 +16.13%
Avalanche $39.61 +10.62%

Bitcoin $99,467.75 +0.71%
Ethereum $3,299.25 -1.52%
BNB $623.04 +0.18%
Optimism $2.11 +2.86%
Arbitrum $0.77 +0.38%
Solana $254.01 -0.61%
Polygon $0.48 +7.00%
Cosmos $7.30 +16.13%
Avalanche $39.61 +10.62%

Verve Therapeutics

company

Investors

Number of Lead Investors

Number of Investors

4

14

Verve Therapeutics is funded by 14 investors. Casdin Capital and Wellington Management are the most recent investors.

Investor Name	Lead Investor	Funding Round
Casdin Capital	Yes	Series B
Wellington Management	Yes	Series B
Biomatics Capital Partners	-	Series B
Cormorant Asset Management	-	Series B
GV	-	Series B
Janus Henderson Investors	-	Series B
Logos Capital	-	Series B
Novo Holdings	-	Series B
RA Capital Management	-	Series B
Redmile Group	-	Series B
Rock Springs Capital	-	Series B
Surveyor Capital	-	Series B
ARCH Venture Partners	-	Series A
F-Prime Capital	-	Series A